1. Home
  2. MBIO vs LICN Comparison

MBIO vs LICN Comparison

Compare MBIO & LICN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBIO
  • LICN
  • Stock Information
  • Founded
  • MBIO 2015
  • LICN 2004
  • Country
  • MBIO United States
  • LICN China
  • Employees
  • MBIO N/A
  • LICN N/A
  • Industry
  • MBIO Biotechnology: Pharmaceutical Preparations
  • LICN
  • Sector
  • MBIO Health Care
  • LICN
  • Exchange
  • MBIO Nasdaq
  • LICN Nasdaq
  • Market Cap
  • MBIO 4.7M
  • LICN 3.8M
  • IPO Year
  • MBIO N/A
  • LICN 2023
  • Fundamental
  • Price
  • MBIO $1.50
  • LICN $3.84
  • Analyst Decision
  • MBIO
  • LICN
  • Analyst Count
  • MBIO 0
  • LICN 0
  • Target Price
  • MBIO N/A
  • LICN N/A
  • AVG Volume (30 Days)
  • MBIO 127.7K
  • LICN 20.0K
  • Earning Date
  • MBIO 11-12-2025
  • LICN 01-01-0001
  • Dividend Yield
  • MBIO N/A
  • LICN N/A
  • EPS Growth
  • MBIO N/A
  • LICN N/A
  • EPS
  • MBIO N/A
  • LICN N/A
  • Revenue
  • MBIO N/A
  • LICN $37,641,000.00
  • Revenue This Year
  • MBIO N/A
  • LICN N/A
  • Revenue Next Year
  • MBIO N/A
  • LICN N/A
  • P/E Ratio
  • MBIO N/A
  • LICN N/A
  • Revenue Growth
  • MBIO N/A
  • LICN N/A
  • 52 Week Low
  • MBIO $0.89
  • LICN $2.60
  • 52 Week High
  • MBIO $21.95
  • LICN $462.00
  • Technical
  • Relative Strength Index (RSI)
  • MBIO 44.43
  • LICN 35.69
  • Support Level
  • MBIO $1.43
  • LICN $3.75
  • Resistance Level
  • MBIO $1.69
  • LICN $4.09
  • Average True Range (ATR)
  • MBIO 0.11
  • LICN 0.25
  • MACD
  • MBIO -0.01
  • LICN -0.06
  • Stochastic Oscillator
  • MBIO 17.07
  • LICN 25.60

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

About LICN Lichen China Limited

Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and sales of financial and taxation training software.

Share on Social Networks: